Profile data is unavailable for this security.
About the company
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
- Revenue in EUR (TTM)2.09bn
- Net income in EUR78.70m
- Incorporated2007
- Employees13.63k
- LocationGerresheimer AGKlaus-Bungert-Strasse 4DUESSELDORF 40468GermanyDEU
- Phone+49 211618100
- Fax+49 2 116181295
- Websitehttps://www.gerresheimer.com/
| Holder | Shares | % Held |
|---|---|---|
| Goldman Sachs Asset Management BVas of 27 Jun 2025 | 3.52m | 10.19% |
| Norges Bank Investment Managementas of 05 Mar 2025 | 1.35m | 3.92% |
| Deka Investment GmbHas of 28 Jan 2025 | 1.30m | 3.76% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 1.28m | 3.71% |
| Asset Value Investors Ltd.as of 18 Mar 2025 | 1.09m | 3.15% |
| Lazard Asset Management Ltd.as of 29 Aug 2024 | 1.03m | 2.99% |
| Artisan Partners LPas of 01 Oct 2024 | 981.94k | 2.84% |
| Eminence Capital LPas of 02 Jun 2025 | 960.85k | 2.78% |
| Teacher Retirement System of Texasas of 04 Apr 2025 | 946.30k | 2.74% |
| Amundi Asset Management SASU (Investment Management)as of 04 Apr 2025 | 913.16k | 2.64% |
